MAPK8 and metabolic disease: This study hypothesized that miRNA-29 targeted inhibition of JNK-1 may be through AMPK signaling, which not only revealed the important role of miR-29 in metabolism, but also provides new ideas for developing novel treatment strategies for obesity and metabolic diseases, and further research is needed to confirm that.